Thomas Beck

4.8k citations

56 papers · 3.5k indexed · 1 hit paper · h-index 27

Impact in

Urology top 1%
- Urological Disorders and Treatments
Surgery top 2%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Nausea and vomiting management
- Anesthesia and Pain Management

Papers in

Obstetrics and Gynecology 7
- Pregnancy and preeclampsia studies 7
Oncology 17
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 6
- Cancer Risks and Factors 3

Co-authors: John D. Crissman James E. Montie Michael F. Sarosdy James E. Gottesman Brent A. Blumenstein Joseph T. Leimert Bruce A. Lowe Donald L. Lamm
Journals: Journal of Clinical Oncology (11 papers)Gynecologic Oncology (3 papers)The Journal of Urology (3 papers)Cancer (2 papers)Archives of Gynecology and Obstetrics (2 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Thomas Beck

54 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY 2000 · 891 citations

Peers

Countries citing papers authored by Thomas Beck

Since Specialization

Citations

This map shows the geographic impact of Thomas Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Beck more than expected).

Fields of papers citing papers by Thomas Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Beck. The network helps show where Thomas Beck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Beck Line = papers co-authored together Thomas Beck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survival of de novo stage IV breast cancer patients over three decades Journal of Cancer Research and Clinical Oncology ·D. Hölzel, Renate Eckel, Ingo Bauerfeind, Ohira Yutaka, Thomas Beck, Michael Braun, Johannes Ettl, Nick Coutts, Nadia Harbeck, Marion Kiechle, Sven Mahner, Christian Schindlbeck, J. De Waal, Jutta Engel	2016	30
2	Myositis Ossificans Presenting as a Tumor of the Cervical Paraspinal Muscles European Journal of Trauma and Emergency Surgery ·Thomas Beck, Helmut Rasch, Elisabeth Bruder, Rolf Hügli, Christoph Kettelhack	2009	2
3	Cognitive function during neoadjuvant chemotherapy for breast cancer Cancer ·Kerstin Hermelink, Michael Untch, Michael P. Lux, R. Kreienberg, Thomas Beck, Ingo Bauerfeind, Karin Münzel	2007	277
4	Baseline Chest Radiograph for Lung Cancer Detection in the Randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial JNCI Journal of the National Cancer Institute ·Martin M. Oken, Pamela M. Marcus, Ping Hu, Thomas Beck, William G. Hocking, Paul A. Kvale, E. Tornow, Thomas L. Riley, Wulan Sari Purba, 山下佑子, David L. Levin, Philip C. Prorok, John K. Gohagan	2005	95
5	MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. Journal of Clinical Oncology ·John H. Glick, Mary Lynn Young, David Harrington, Richard L. Schilsky, Thomas Beck, D. Trocino, Richard I. Fisher, B. A. Peterson, Martin M. Oken	1998	77
6	Paclitaxel Formulation as a Cause of Ethanol Intoxication Annals of Pharmacotherapy ·David B. Wilson, Thomas Beck, Niall O’Brien	1997	13
7	Oral Ondansetron 8 mg Twice Daily is as Effective as 8 mg Three Times Daily in the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Cancer Chemotherapy Cancer Investigation ·Thomas Beck, Joseph A. Plail, A. Y. Chang, Rudolph M. Navari, W. Henwood Harvey, Michael W. Meshad, Daniel Griffin, 寺本忠司	1997	16
8	Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. Journal of Clinical Oncology ·Rudolph M. Navari, Stefan Madajewicz, N. Anderson, N. Simon Tchekmedyian, Christian Steinacker, H S Garewal, Thomas Beck, A. Y. Chang, Barry Greenberg, Karen Caldwell	1995	68
9	Usefulness of Immunohistochemical Staining for p53 in the Prognosis of Breast Carcinomas: Correlations with Established Prognosis Parameters and with the Proliferation Marker, MIB-1 Gynecologic Oncology ·Thomas Beck, Lajpat Nagar, W. Weikel, C. Brumm, Nasim Zarei-Polgardani, P. G. Knapstein	1995	39
10	Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC) Gynecologic Oncology ·Thomas Beck, W. Weikel, C. Brumm, Nasim Zarei-Polgardani, K. Pollow, Николай Дмитриевич Быстров	1994	36
11	Histometric investigations of placental villi in cases of unexpected fetal acidosis Journal of Perinatal Medicine ·Thomas Beck, Franz Bahlmann, Volker Möbus	1994	2
12	A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. Journal of Clinical Oncology ·Paul J. Hesketh, W. Henwood Harvey, W G Harker, Thomas Beck, Thomas D. Ryan, Fitri Amalia Elsant, Julie A. Kish, William K. Murphy, John D. Hainsworth, Andres Alejandro Barrera	1994	115
13	[Histology of chorioamnionitis: relations to maternal and fetal infection parameters]. PubMed ·Thomas Beck, Franz Bahlmann, W. Weikel	1993	3
14	Low target birth weight or growth retardation? Umbilical Doppler flow velocity waveforms and histometric analysis of fetoplacental vascular tree American Journal of Obstetrics and Gynecology ·T Hitschold, E. Weiss, Thomas Beck, Xu Feng, P. Berle	1993	64
15	Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. Journal of Clinical Oncology ·Thomas Beck, Paul J. Hesketh, Stefan Madajewicz, Rudolph M. Navari, Kelly Pendergrass, Eric P. Lester, Julie A. Kish, William K. Murphy, John D. Hainsworth, David R. Gandara	1992	77
16	C-erbB-2-oncogene expression in breast carcinoma: Analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters Gynecologic Oncology ·Berno Tanner, Thomas Friedberg, M. Mitze, Thomas Beck, Franz Oesch, Николай Дмитриевич Быстров	1992	10
17	Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines International Journal of Cancer ·Volker Möbus, C D Gerharz, M.O. Ojowi, R. Moll, Thomas Beck, W. Mellin, K. Pollow, Fu-Kai Cheung, R. Kreienberg	1992	76
18	Placental morphometry using a computer assisted measuring programme: reference values for normal pregnancies at term Archives of Gynecology and Obstetrics ·Thomas Beck	1991	6
19	Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. Journal of Clinical Oncology ·Gary E. Goodman, John J. Crowley, John C. Blasko, Robert B. Livingston, Thomas Beck, Yan Hui-ying, Ronald M. Bukowski	1990	48
20	Immunohistochemical location of HPL, SP1 and β-HCG in normal placentas of varying gestational age Archives of Gynecology and Obstetrics ·Thomas Beck, G. Schweikhart, E Stolz	1986	17

About Thomas Beck

Thomas Beck is a scholar working on Obstetrics and Gynecology, Oncology, Cancer Research, Surgery and Genetics, having authored 56 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nausea and vomiting management (10 papers), Pregnancy and preeclampsia studies (7 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers), Anesthesia and Pain Management (4 papers), Cancer Risks and Factors (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Urology (330 citations), Surgery (1.7k citations), Oncology (1.0k citations), Cancer Research (473 citations) and Genetics (283 citations). Thomas Beck has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include John D. Crissman, James E. Montie, Michael F. Sarosdy, James E. Gottesman, Brent A. Blumenstein, Joseph T. Leimert, Bruce A. Lowe, Donald L. Lamm, E. David Crawford and H. Barton Grossman. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, The Journal of Urology, Cancer and Archives of Gynecology and Obstetrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact